SenesTech, Inc. (SNES) Reports FY17 EPS Loss of $1.12
Get Alerts SNES Hot Sheet
Join SI Premium – FREE
Note: EPS may not be comparable
SenesTech, Inc. (NASDAQ: SNES) reported FY17 EPS Loss of $1.12.
2017 Annual Financial Results
- Revenues from product sales during 2017 were $52,000, compared to less than $1,000 of revenue from product sales during 2016. During 2016, the company received $132,000 in NIH grants, and $186,000 in licensing fees under our former license agreement with Neogen.
- Operating expenses during 2017 were $12.3 million, compared to $10.8 million during 2016. Operating expenses during 2017 included non-cash equity compensation of $3.7 million. The increase in operating expense was attributable largely to expansion of product commercialization activities. The Company anticipates that operating cash utilization will continue at or below $750,000 per month.
- Net loss during 2017 was $12.3 million or $1.12 per share, compared to $11.0 million, or $1.71 per share, during 2016.
- Adjusted EBITDA, which is a non-GAAP measure of operating performance, was $(8.2) million during 2017, compared to $(6.0) million during 2016.
- Cash, cash equivalents and highly liquid investments at the end of the year were $7.1 million.
For earnings history and earnings-related data on SenesTech, Inc. (SNES) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Visa (V) Tops Q2 EPS by 7c, offers guidance
- Mattel (MAT) Tops Q1 EPS by 7c, Revenue Misses, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!